MTOR and cardiac hypertrophy: In male Zucker diabetic fatty rat HFpEF models, dapagliflozin was found to reduce nitro-oxidative stress, pro-inflammatory cytokine levels, myocardial hypertrophy, and fibrosis, effectively preventing the onset of HFpEF through AMPK activation and inhibition of the mTOR pathway.113